METI expects global regenerative medicine markets to reach 17,2 trillion Yen (126 billion €) by 2030

A major part of this market will be based on iPS cell technology. iPS-based blood products alone might reach 60 billion Yen in the late 2020ies.

China Bio news release, October 13, 2014

Most popular posts: